El Khoury Raghid, Chahrouri Mario, Hachem Charbel, Abi Zeid Joseph, El Alam Paul, Abdessater Maher
J Med Liban. 2016 Aug;64(2):84-90.
The objective of this study was to examine the impact of multidisciplinary team meetings on the management decisions for urological cancers. A pro- spective study was conducted.
The study popu- lation is cases presented to multidisciplinary teams at Notre- Dame de Secours University Medical Center between July 2012 and July 2014. Data was collected by a standard pro forma.
189 cases were presented in multidisci- plinary meetings during the study period. Results of this study showed that multidisciplinary team meetings change management decisions in 40.7% of cases. Change in man- agement decisions was mainly significant in testicular can- cer (57.1%), prostate cancer (42.7%) and bladder cancer (38.2%), with less important changes in renal cancer (33.3%). Prostate cancer cases with Gleason score 7 (51.7%) and bladder tumors with TNM ;t T2 (85.7%) were the most mod- ified in their respective groups.
Multidiscipli- nary team meetings have a major impact in therapeutic de- cisions taken by urologists for newly diagnosed urological cancers.
本研究的目的是探讨多学科团队会议对泌尿生殖系统癌症管理决策的影响。进行了一项前瞻性研究。
研究人群为2012年7月至2014年7月期间在巴黎圣母院大学医学中心多学科团队就诊的病例。数据通过标准表格收集。
在研究期间，多学科会议共讨论了189例病例。本研究结果显示，多学科团队会议在40.7%的病例中改变了管理决策。管理决策的改变在睾丸癌（57.1%）、前列腺癌（42.7%）和膀胱癌（38.2%）中最为显著，而在肾癌（33.3%）中变化较小。在各自组中，Gleason评分为7的前列腺癌病例（51.7%）和TNM≥T2的膀胱肿瘤（85.7%）改变最大。
多学科团队会议对泌尿外科医生针对新诊断的泌尿生殖系统癌症所做出的治疗决策有重大影响。
